Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High FLT3 expression indicates favorable prognosis and correlates with clinicopathological parameters and immune infiltration in breast cancer

8 Sept 2022

Abstract excerpt

Purpose: Breast cancer is a highly heterogeneous malignancy, seriously threatening female health worldwide and inducing higher mortalities. Few have the studies evaluated Fms-like TyrosineKinase-3 (FLT3) in prognostic risk, immunotherapy or any other treatment of breast cancer. Our study focused on investigating the function of FLT3 in breast cancer. Patients and methods: Based on transcriptome and methylation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Immunotherapy and Immune Responses

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36159964
DOI: 10.3389/fgene.2022.956869

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High FLT3 expression indicates favorable prognosis and correlates with clinicopathological parameters and immune infiltration in breast cancerPMID 36159964Read ↗

Association of GATA3 expression in triple-positive breast cancer with overall survival and immune cell infiltrationSemantic proximity Read ↗

FGFR3 mutation characterization identifies prognostic and immune-related gene signatures in bladder cancer.Semantic proximity Read ↗

Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancerSemantic proximity Read ↗

Identification of FPR3 as a unique biomarker for targeted therapy in the immune microenvironment of breast cancerSemantic proximity Read ↗

Tumor Mutation Burden and Immune Invasion Characteristics in Triple Negative Breast Cancer: Genome High-Throughput Data Analysis.Semantic proximity Read ↗

Prognostic Value of HIF1A-AS3 in Breast cancerSemantic proximity Read ↗

GATA3 mutations define a unique subtype of luminal-like breast cancer with improved survival.Semantic proximity Read ↗

High expression of TLR3 in triple-negative breast cancer predicts better prognosis —data from the Fudan University Shanghai Cancer Center cohort and tissue microarraysSemantic proximity Read ↗

Identification of FPR3 as a Unique Biomarker for Targeted Therapy in the Immune Microenvironment of Breast CancerSemantic proximity Read ↗

Transcriptomic immunologic signature associated with favorable clinical outcome in basal-like breast tumorsSemantic proximity Read ↗

Clinical implications of a novel prognostic factor AIFM3 in breast cancer patientsSemantic proximity Read ↗

GATA3 somatic mutations are associated with clinicopathological features and expression profile in TCGA breast cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.